CYP2B6 and acute myeloid leukemia: In conclusion, our results provide evidence for a pathogenetic role of the G516T CYP2B6 polymorphism on AML susceptibility suggesting that inherited defective function of the CYP2B6 detoxification pathway may be an important genetic determinant of AML risk.